Mitarbeiterinnen und Mitarbeiter
Publikationen
Mensching L, Beiersdorfer M, Schloer S, Köllmann S, Reinsberg F, Padoan B, Fittje P, Trenkner T, Zaayenga A, Martrus G, Almahfoud M, Stürzel CM, Sauter D, Kirchhoff F, Schulze Zur Wiesch J, Altfeld M, Garcia-Beltran WF, Hoelzemer A (2025). HIV-1 infection of macrophages differentially primes NK-cell cytotoxicity and proinflammatory cytokine production. iScience. 28/2025; PubMed
Gorgulho J, Trenkner T, Kinkel E, Fritzsche B, Kachel P, Peine S, Matschl U, Altfeld M, Huber S, Lohse AW, Alsdorf W, Bokemeyer C, Hoelzemer A, Beltran WG, von Felden J (2025). A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patients. Oncoimmunology. 14/2025; PubMed
Aziz UBA, Saoud A, Bermudez M, Mieth M, Atef A, Rudolf T, Arkona C, Trenkner T, Böttcher C, Ludwig K, Hoelzemer A, Hocke AC, Wolber G, Rademann J (2024). Author Correction: Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins. Nat Commun. 15/2024; PubMed
Aziz UBA, Saoud A, Bermudez M, Mieth M, Atef A, Rudolf T, Arkona C, Trenkner T, Böttcher C, Ludwig K, Hoelzemer A, Hocke AC, Wolber G, Rademann J (2024). Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins. Nat Commun. 15/2024; PubMed
Vollmers S, Lobermeyer A, Niehrs A, Fittje P, Indenbirken D, Nakel J, Virdi S, Brias S, Trenkner T, Sauer G, Peine S, Behrens GMN, Lehmann C, Meurer A, Pauli R, Postel N, Roider J, Scholten S, Spinner CD, Stephan C, Wolf E, Wyen C, Richert L, Norman PJ, Sauter J, Schmidt AH, Hoelzemer A, Altfeld M, Körner C (2022). Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C. Front Immunol. 13/2022; PubMed
Höfle J, Trenkner T, Kleist N, Schwane V, Vollmers S, Barcelona B, Niehrs A, Fittje P, Huynh-Tran VH, Sauter J, Schmidt AH, Peine S, Hoelzemer A, Richert L, Altfeld M, Körner C (2022). Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells. EMBO Rep. 23/2022; PubMed
